Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin antiviral effects in healthy volunteers
NCT05303909Phase 2Terminated
- Sponsor
- Singapore General Hospital
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in yellow fever, sponsored by Singapore General Hospital. Started May 2022; status: terminated.
02
Drugs
gentamicin
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT05303909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303909.